Park Ha Biological (BYAH) investors disclose 9.8% positions via shares and warrants

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. received a Schedule 13G filing from Rove Trading Co., Limited and Yingying Guo, disclosing significant holdings of its Class A Ordinary Shares, par value $0.008 per share, CUSIP G6925R128.

Each reporting person is shown with 422,500 Class A Ordinary Shares of beneficial ownership and a 9.8% stake in the class, including 260,000 shares issuable upon exercise of warrants within 60 days. The ownership percentage is calculated based on 2,297,902 Class A Ordinary Shares outstanding following a reverse stock split effective August 6, 2026, plus 2,000,000 shares underlying a warrant that is also exercisable within 60 days. Both report sole voting and dispositive power over their respective positions.

Key Figures

Beneficial ownership per reporting person: 422,500 Class A Ordinary Shares Ownership percentage: 9.8% Shares via warrants per holder: 260,000 Class A Ordinary Shares +3 more

6 metrics

Beneficial ownership per reporting person 422,500 Class A Ordinary Shares Beneficially owned by each of Rove Trading Co., Limited and Yingying Guo

Ownership percentage 9.8% Percent of Class A Ordinary Shares for each reporting person

Shares via warrants per holder 260,000 Class A Ordinary Shares Included in each reporting person’s beneficial ownership, exercisable within 60 days

Shares outstanding post-split 2,297,902 Class A Ordinary Shares Outstanding following reverse stock split effective August 6, 2026

Additional warrant base shares 2,000,000 Class A Ordinary Shares Underlying a warrant exercisable within 60 days, included in ownership base

Par value per share $0.008 per Class A Ordinary Share Stated par value of Park Ha Biological Class A Ordinary Shares

Key Terms

beneficially owned, reverse stock split, sole voting power, sole dispositive power, +1 more

5 terms

beneficially owned financial

"Ownership (a) | Amount beneficially owned: Rove Trading Co., Limited..."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

reverse stock split financial

"Class A Ordinary Shares outstanding following the effectiveness of the reverse stock split on August 6, 2026"

A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.

sole voting power financial

"5 | Sole Voting Power 422,500.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"7 | Sole Dispositive Power 422,500.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Class A Ordinary Shares financial

"Title of class of securities: Class A Ordinary Shares, par value $0.008 per share"

Class A ordinary shares are a type of ownership stake in a company that typically grants voting rights to shareholders, allowing them to have a say in important company decisions. They often come with priority in receiving dividends or profits, making them attractive to investors seeking influence and potential income. These shares help distinguish different levels of ownership and rights within a company's stock structure.

FAQ

What stake in Park Ha Biological (BYAH) does Rove Trading report on this Schedule 13G?

Rove Trading Co., Limited reports beneficial ownership of 422,500 Class A Ordinary Shares of Park Ha Biological, representing 9.8% of the outstanding Class A Ordinary Shares, including 260,000 shares issuable upon exercise of warrants within 60 days.

How many Park Ha Biological (BYAH) shares does Yingying Guo beneficially own?

Yingying Guo reports beneficial ownership of 422,500 Class A Ordinary Shares, representing 9.8% of the company’s Class A Ordinary Shares, which includes 260,000 shares that can be acquired through warrant exercises within the next 60 days.

What share count did Park Ha Biological (BYAH) use to calculate the 9.8% ownership?

The 9.8% ownership is based on 2,297,902 Class A Ordinary Shares outstanding after a reverse stock split effective August 6, 2026, plus 2,000,000 Class A Ordinary Shares underlying a warrant that is exercisable within the next 60 days.

Do the reporting persons on this 13G for Park Ha Biological (BYAH) have sole voting power?

Yes. Each reporting person is listed with sole voting power over 422,500 shares and no shared voting power, and likewise sole dispositive power over the same number of Class A Ordinary Shares.

How are warrants reflected in the reported ownership for Park Ha Biological (BYAH)?

Each reporting person’s stake includes 260,000 Class A Ordinary Shares issuable upon exercise of warrants within 60 days. In addition, the ownership percentage calculation counts 2,000,000 underlying warrant shares exercisable within 60 days in the total share base.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 09:19 PM Accepted by SEC EDGAR 08/10/2026 - 09:18 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Park Ha Biological Technology Co., Ltd.

(Name of Issuer)

Class A Ordinary Shares, par value $0.008 per share

(Title of Class of Securities)

G6925R128

(CUSIP Number)

08/03/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): G6925R128

1

Names of Reporting Persons

Rove Trading Co., Limited

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

HONG KONG

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 422,500.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 422,500.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

422,500.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.8 %

12

Type of Reporting Person (See Instructions)

CO

Comment for Type of Reporting Person: (1) Includes 260,000 Class A Ordinary Shares for which Warrants are exercisable within the next 60 days. (2) Based on (i) 2,297,902 Class A Ordinary Shares outstanding following the effectiveness of the reverse stock split on August 6, 2026, as set forth in the Issuer's Form 6-K filed with the Securities and Exchange Commission ("SEC") on August 3, 2026 plus (ii) 2,000,000 Class A Ordinary Shares underlying a warrant which is exercisable within the next 60 days.

SCHEDULE 13G

CUSIP Number(s): G6925R128

1

Names of Reporting Persons

Yingying Guo

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CHINA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 422,500.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 422,500.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

422,500.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.8 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: (1) Includes 260,000 Class A Ordinary Shares for which Warrants are exercisable within the next 60 days. (2) Based on (i) 2,297,902 Class A Ordinary Shares outstanding following the effectiveness of the reverse stock split on August 6, 2026, as set forth in the Issuer's Form 6-K filed with the SEC on August 3, 2026 plus (ii) 2,000,000 Class A Ordinary Shares underlying a warrant which is exercisable within the next 60 days.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Park Ha Biological Technology Co., Ltd.
(b)	Address of issuer's principal executive offices: 901 & 902-2, Building C, Phase 2, Wuxi International Life Science Innovation Campus, 196 Jinghui East Road, Xinwu District, Wuxi, Jiangsu Province, Ch
Item 2.
(a)	Name of person filing: Rove Trading Co., Limited, and Yingying Guo (each, a "Reporting Person" and collectively, the "Reporting Persons")
(b)	Address or principal business office or, if none, residence: The address of the principal business office of each of the reporting persons is No. 2, Row 2, Zone 1, Anlezhuang Village, Koudong Street, Baodi District, Tianjin City, China.
(c)	Citizenship: See Item 4 on the cover page hereto.
(d)	Title of class of securities: Class A Ordinary Shares, par value $0.008 per share
(e)	CUSIP Number(s): G6925R128
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Rove Trading Co., Limited: 425,500; and Yingying Guo: 422,500. Ownership percentages are based on (i) 2,297,902 Class A Ordinary Shares outstanding following the effectiveness of the reverse stock split on August 6, 2026, as set forth in the Issuer's Form 6-K filed with the SEC on August 3, 2026 plus (ii) 2,000,000 Class A Ordinary Shares underlying a warrant which is exercisable within the next 60 days.
(b)	Percent of class: See response to Item 11 on the cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on the cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on the cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on the cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on the cover page.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Rove Trading Co., Limited

Signature:	/s/ Yingying Guo
Name/Title:	Yingying Guo, Director
Date:	08/10/2026

Yingying Guo

Signature:	/s/ Yingying Guo
Name/Title:	Yingying Guo
Date:	08/10/2026